img

Global Biobetter Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Biobetter Market Insights, Forecast to 2034

Biobetters, also known as biosuperiors, are recombinant protein drugs from an identical class as a present set of biopharmaceuticals is not similar to the source. It is neither a wholly novel medicine nor a generic version of an old drug. It is a biological product designed to increase clinical efficacy while also improving tolerance and lowering dosing/administration frequency.
Global Biobetter market is expected to reach to US$ 912 million in 2024, with a positive growth of %, compared with US$ 832 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Biobetter industry is evaluated to reach US$ 1538 million in 2029. The CAGR will be 9.1% during 2024 to 2029.
According to the Global Use of Medicines 2024 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Report Covers
This report presents an overview of global Biobetter market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Biobetter market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


F.Hoffmann-La Roche AG
Merck and Co.
Sanofi
SERVIER
Porton Biopharma
Eli Lily and Company
Novo Nordisk
Biogen
CSL Behring GmbH
Teva
Segment by Type
G-CSF Biobetters
Insulin Biobetters
Erythropoietin Biobetters
Monoclonal Antibodies Biobetters
Others

Segment by Application


Cancer
Diabetes
Genetic Disease
Neurological Disorders
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Biobetter plant distribution, commercial date of Biobetter, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Biobetter introduction, etc. Biobetter Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Biobetter
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Biobetter Product Introduction
1.2 Market by Type
1.2.1 Global Biobetter Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 G-CSF Biobetters
1.2.3 Insulin Biobetters
1.2.4 Erythropoietin Biobetters
1.2.5 Monoclonal Antibodies Biobetters
1.2.6 Others
1.3 Market by Application
1.3.1 Global Biobetter Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Genetic Disease
1.3.5 Neurological Disorders
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biobetter Sales Estimates and Forecasts 2018-2029
2.2 Global Biobetter Revenue by Region
2.2.1 Global Biobetter Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Biobetter Revenue by Region (2018-2024)
2.2.3 Global Biobetter Revenue by Region (2024-2029)
2.2.4 Global Biobetter Revenue Market Share by Region (2018-2029)
2.3 Global Biobetter Sales Estimates and Forecasts 2018-2029
2.4 Global Biobetter Sales by Region
2.4.1 Global Biobetter Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Biobetter Sales by Region (2018-2024)
2.4.3 Global Biobetter Sales by Region (2024-2029)
2.4.4 Global Biobetter Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Biobetter Sales by Manufacturers
3.1.1 Global Biobetter Sales by Manufacturers (2018-2024)
3.1.2 Global Biobetter Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biobetter in 2022
3.2 Global Biobetter Revenue by Manufacturers
3.2.1 Global Biobetter Revenue by Manufacturers (2018-2024)
3.2.2 Global Biobetter Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Biobetter Revenue in 2022
3.3 Global Key Players of Biobetter, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Biobetter Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Biobetter Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Biobetter, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Biobetter, Product Offered and Application
3.8 Global Key Manufacturers of Biobetter, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biobetter Sales by Type
4.1.1 Global Biobetter Historical Sales by Type (2018-2024)
4.1.2 Global Biobetter Forecasted Sales by Type (2024-2029)
4.1.3 Global Biobetter Sales Market Share by Type (2018-2029)
4.2 Global Biobetter Revenue by Type
4.2.1 Global Biobetter Historical Revenue by Type (2018-2024)
4.2.2 Global Biobetter Forecasted Revenue by Type (2024-2029)
4.2.3 Global Biobetter Revenue Market Share by Type (2018-2029)
4.3 Global Biobetter Price by Type
4.3.1 Global Biobetter Price by Type (2018-2024)
4.3.2 Global Biobetter Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Biobetter Sales by Application
5.1.1 Global Biobetter Historical Sales by Application (2018-2024)
5.1.2 Global Biobetter Forecasted Sales by Application (2024-2029)
5.1.3 Global Biobetter Sales Market Share by Application (2018-2029)
5.2 Global Biobetter Revenue by Application
5.2.1 Global Biobetter Historical Revenue by Application (2018-2024)
5.2.2 Global Biobetter Forecasted Revenue by Application (2024-2029)
5.2.3 Global Biobetter Revenue Market Share by Application (2018-2029)
5.3 Global Biobetter Price by Application
5.3.1 Global Biobetter Price by Application (2018-2024)
5.3.2 Global Biobetter Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Biobetter Market Size by Type
6.1.1 US & Canada Biobetter Sales by Type (2018-2029)
6.1.2 US & Canada Biobetter Revenue by Type (2018-2029)
6.2 US & Canada Biobetter Market Size by Application
6.2.1 US & Canada Biobetter Sales by Application (2018-2029)
6.2.2 US & Canada Biobetter Revenue by Application (2018-2029)
6.3 US & Canada Biobetter Market Size by Country
6.3.1 US & Canada Biobetter Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Biobetter Sales by Country (2018-2029)
6.3.3 US & Canada Biobetter Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Biobetter Market Size by Type
7.1.1 Europe Biobetter Sales by Type (2018-2029)
7.1.2 Europe Biobetter Revenue by Type (2018-2029)
7.2 Europe Biobetter Market Size by Application
7.2.1 Europe Biobetter Sales by Application (2018-2029)
7.2.2 Europe Biobetter Revenue by Application (2018-2029)
7.3 Europe Biobetter Market Size by Country
7.3.1 Europe Biobetter Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Biobetter Sales by Country (2018-2029)
7.3.3 Europe Biobetter Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Biobetter Market Size
8.1.1 China Biobetter Sales (2018-2029)
8.1.2 China Biobetter Revenue (2018-2029)
8.2 China Biobetter Market Size by Application
8.2.1 China Biobetter Sales by Application (2018-2029)
8.2.2 China Biobetter Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Biobetter Market Size by Type
9.1.1 Asia Biobetter Sales by Type (2018-2029)
9.1.2 Asia Biobetter Revenue by Type (2018-2029)
9.2 Asia Biobetter Market Size by Application
9.2.1 Asia Biobetter Sales by Application (2018-2029)
9.2.2 Asia Biobetter Revenue by Application (2018-2029)
9.3 Asia Biobetter Sales by Region
9.3.1 Asia Biobetter Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Biobetter Revenue by Region (2018-2029)
9.3.3 Asia Biobetter Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Biobetter Market Size by Type
10.1.1 Middle East, Africa and Latin America Biobetter Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Biobetter Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Biobetter Market Size by Application
10.2.1 Middle East, Africa and Latin America Biobetter Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Biobetter Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Biobetter Sales by Country
10.3.1 Middle East, Africa and Latin America Biobetter Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Biobetter Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Biobetter Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 F.Hoffmann-La Roche AG
11.1.1 F.Hoffmann-La Roche AG Company Information
11.1.2 F.Hoffmann-La Roche AG Overview
11.1.3 F.Hoffmann-La Roche AG Biobetter Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 F.Hoffmann-La Roche AG Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 F.Hoffmann-La Roche AG Recent Developments
11.2 Merck and Co.
11.2.1 Merck and Co. Company Information
11.2.2 Merck and Co. Overview
11.2.3 Merck and Co. Biobetter Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Merck and Co. Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck and Co. Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Biobetter Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Sanofi Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 SERVIER
11.4.1 SERVIER Company Information
11.4.2 SERVIER Overview
11.4.3 SERVIER Biobetter Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 SERVIER Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 SERVIER Recent Developments
11.5 Porton Biopharma
11.5.1 Porton Biopharma Company Information
11.5.2 Porton Biopharma Overview
11.5.3 Porton Biopharma Biobetter Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Porton Biopharma Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Porton Biopharma Recent Developments
11.6 Eli Lily and Company
11.6.1 Eli Lily and Company Company Information
11.6.2 Eli Lily and Company Overview
11.6.3 Eli Lily and Company Biobetter Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Eli Lily and Company Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eli Lily and Company Recent Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Information
11.7.2 Novo Nordisk Overview
11.7.3 Novo Nordisk Biobetter Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Novo Nordisk Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novo Nordisk Recent Developments
11.8 Biogen
11.8.1 Biogen Company Information
11.8.2 Biogen Overview
11.8.3 Biogen Biobetter Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Biogen Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biogen Recent Developments
11.9 CSL Behring GmbH
11.9.1 CSL Behring GmbH Company Information
11.9.2 CSL Behring GmbH Overview
11.9.3 CSL Behring GmbH Biobetter Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 CSL Behring GmbH Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 CSL Behring GmbH Recent Developments
11.10 Teva
11.10.1 Teva Company Information
11.10.2 Teva Overview
11.10.3 Teva Biobetter Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Teva Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teva Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biobetter Industry Chain Analysis
12.2 Biobetter Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biobetter Production Mode & Process
12.4 Biobetter Sales and Marketing
12.4.1 Biobetter Sales Channels
12.4.2 Biobetter Distributors
12.5 Biobetter Customers
13 Market Dynamics
13.1 Biobetter Industry Trends
13.2 Biobetter Market Drivers
13.3 Biobetter Market Challenges
13.4 Biobetter Market Restraints
14 Key Findings in The Global Biobetter Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Biobetter Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of G-CSF Biobetters
Table 3. Major Manufacturers of Insulin Biobetters
Table 4. Major Manufacturers of Erythropoietin Biobetters
Table 5. Major Manufacturers of Monoclonal Antibodies Biobetters
Table 6. Major Manufacturers of Others
Table 7. Global Biobetter Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Biobetter Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Biobetter Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Biobetter Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Biobetter Revenue Market Share by Region (2018-2024)
Table 12. Global Biobetter Revenue Market Share by Region (2024-2029)
Table 13. Global Biobetter Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Biobetter Sales by Region (2018-2024) & (K Units)
Table 15. Global Biobetter Sales by Region (2024-2029) & (K Units)
Table 16. Global Biobetter Sales Market Share by Region (2018-2024)
Table 17. Global Biobetter Sales Market Share by Region (2024-2029)
Table 18. Global Biobetter Sales by Manufacturers (2018-2024) & (K Units)
Table 19. Global Biobetter Sales Share by Manufacturers (2018-2024)
Table 20. Global Biobetter Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Biobetter Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of Biobetter, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Biobetter Price by Manufacturers 2018-2024 (US$/Unit)
Table 24. Global Biobetter Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Biobetter by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biobetter as of 2022)
Table 26. Global Key Manufacturers of Biobetter, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Biobetter, Product Offered and Application
Table 28. Global Key Manufacturers of Biobetter, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Biobetter Sales by Type (2018-2024) & (K Units)
Table 31. Global Biobetter Sales by Type (2024-2029) & (K Units)
Table 32. Global Biobetter Sales Share by Type (2018-2024)
Table 33. Global Biobetter Sales Share by Type (2024-2029)
Table 34. Global Biobetter Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Biobetter Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Biobetter Revenue Share by Type (2018-2024)
Table 37. Global Biobetter Revenue Share by Type (2024-2029)
Table 38. Biobetter Price by Type (2018-2024) & (US$/Unit)
Table 39. Global Biobetter Price Forecast by Type (2024-2029) & (US$/Unit)
Table 40. Global Biobetter Sales by Application (2018-2024) & (K Units)
Table 41. Global Biobetter Sales by Application (2024-2029) & (K Units)
Table 42. Global Biobetter Sales Share by Application (2018-2024)
Table 43. Global Biobetter Sales Share by Application (2024-2029)
Table 44. Global Biobetter Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Biobetter Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Biobetter Revenue Share by Application (2018-2024)
Table 47. Global Biobetter Revenue Share by Application (2024-2029)
Table 48. Biobetter Price by Application (2018-2024) & (US$/Unit)
Table 49. Global Biobetter Price Forecast by Application (2024-2029) & (US$/Unit)
Table 50. US & Canada Biobetter Sales by Type (2018-2024) & (K Units)
Table 51. US & Canada Biobetter Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada Biobetter Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada Biobetter Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Biobetter Sales by Application (2018-2024) & (K Units)
Table 55. US & Canada Biobetter Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada Biobetter Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada Biobetter Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Biobetter Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Biobetter Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada Biobetter Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Biobetter Sales by Country (2018-2024) & (K Units)
Table 62. US & Canada Biobetter Sales by Country (2024-2029) & (K Units)
Table 63. Europe Biobetter Sales by Type (2018-2024) & (K Units)
Table 64. Europe Biobetter Sales by Type (2024-2029) & (K Units)
Table 65. Europe Biobetter Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe Biobetter Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Biobetter Sales by Application (2018-2024) & (K Units)
Table 68. Europe Biobetter Sales by Application (2024-2029) & (K Units)
Table 69. Europe Biobetter Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe Biobetter Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Biobetter Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Biobetter Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe Biobetter Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Biobetter Sales by Country (2018-2024) & (K Units)
Table 75. Europe Biobetter Sales by Country (2024-2029) & (K Units)
Table 76. China Biobetter Sales by Type (2018-2024) & (K Units)
Table 77. China Biobetter Sales by Type (2024-2029) & (K Units)
Table 78. China Biobetter Revenue by Type (2018-2024) & (US$ Million)
Table 79. China Biobetter Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Biobetter Sales by Application (2018-2024) & (K Units)
Table 81. China Biobetter Sales by Application (2024-2029) & (K Units)
Table 82. China Biobetter Revenue by Application (2018-2024) & (US$ Million)
Table 83. China Biobetter Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Biobetter Sales by Type (2018-2024) & (K Units)
Table 85. Asia Biobetter Sales by Type (2024-2029) & (K Units)
Table 86. Asia Biobetter Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia Biobetter Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Biobetter Sales by Application (2018-2024) & (K Units)
Table 89. Asia Biobetter Sales by Application (2024-2029) & (K Units)
Table 90. Asia Biobetter Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia Biobetter Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Biobetter Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Biobetter Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia Biobetter Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Biobetter Sales by Region (2018-2024) & (K Units)
Table 96. Asia Biobetter Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Biobetter Sales by Type (2018-2024) & (K Units)
Table 98. Middle East, Africa and Latin America Biobetter Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Biobetter Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Biobetter Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Biobetter Sales by Application (2018-2024) & (K Units)
Table 102. Middle East, Africa and Latin America Biobetter Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America Biobetter Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Biobetter Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Biobetter Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Biobetter Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Biobetter Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Biobetter Sales by Country (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Biobetter Sales by Country (2024-2029) & (K Units)
Table 110. F.Hoffmann-La Roche AG Company Information
Table 111. F.Hoffmann-La Roche AG Description and Major Businesses
Table 112. F.Hoffmann-La Roche AG Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. F.Hoffmann-La Roche AG Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. F.Hoffmann-La Roche AG Recent Developments
Table 115. Merck and Co. Company Information
Table 116. Merck and Co. Description and Major Businesses
Table 117. Merck and Co. Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Merck and Co. Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Merck and Co. Recent Developments
Table 120. Sanofi Company Information
Table 121. Sanofi Description and Major Businesses
Table 122. Sanofi Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Sanofi Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sanofi Recent Developments
Table 125. SERVIER Company Information
Table 126. SERVIER Description and Major Businesses
Table 127. SERVIER Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. SERVIER Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. SERVIER Recent Developments
Table 130. Porton Biopharma Company Information
Table 131. Porton Biopharma Description and Major Businesses
Table 132. Porton Biopharma Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Porton Biopharma Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Porton Biopharma Recent Developments
Table 135. Eli Lily and Company Company Information
Table 136. Eli Lily and Company Description and Major Businesses
Table 137. Eli Lily and Company Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Eli Lily and Company Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Eli Lily and Company Recent Developments
Table 140. Novo Nordisk Company Information
Table 141. Novo Nordisk Description and Major Businesses
Table 142. Novo Nordisk Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Novo Nordisk Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Novo Nordisk Recent Developments
Table 145. Biogen Company Information
Table 146. Biogen Description and Major Businesses
Table 147. Biogen Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Biogen Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Biogen Recent Developments
Table 150. CSL Behring GmbH Company Information
Table 151. CSL Behring GmbH Description and Major Businesses
Table 152. CSL Behring GmbH Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. CSL Behring GmbH Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. CSL Behring GmbH Recent Developments
Table 155. Teva Company Information
Table 156. Teva Description and Major Businesses
Table 157. Teva Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Teva Biobetter Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Teva Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Biobetter Distributors List
Table 163. Biobetter Customers List
Table 164. Biobetter Market Trends
Table 165. Biobetter Market Drivers
Table 166. Biobetter Market Challenges
Table 167. Biobetter Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Biobetter Product Picture
Figure 2. Global Biobetter Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Biobetter Market Share by Type in 2022 & 2029
Figure 4. G-CSF Biobetters Product Picture
Figure 5. Insulin Biobetters Product Picture
Figure 6. Erythropoietin Biobetters Product Picture
Figure 7. Monoclonal Antibodies Biobetters Product Picture
Figure 8. Others Product Picture
Figure 9. Global Biobetter Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Biobetter Market Share by Application in 2022 & 2029
Figure 11. Cancer
Figure 12. Diabetes
Figure 13. Genetic Disease
Figure 14. Neurological Disorders
Figure 15. Others
Figure 16. Biobetter Report Years Considered
Figure 17. Global Biobetter Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Biobetter Revenue 2018-2029 (US$ Million)
Figure 19. Global Biobetter Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 20. Global Biobetter Revenue Market Share by Region (2018-2029)
Figure 21. Global Biobetter Sales 2018-2029 ((K Units)
Figure 22. Global Biobetter Sales Market Share by Region (2018-2029)
Figure 23. US & Canada Biobetter Sales YoY (2018-2029) & (K Units)
Figure 24. US & Canada Biobetter Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Europe Biobetter Sales YoY (2018-2029) & (K Units)
Figure 26. Europe Biobetter Revenue YoY (2018-2029) & (US$ Million)
Figure 27. China Biobetter Sales YoY (2018-2029) & (K Units)
Figure 28. China Biobetter Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Asia (excluding China) Biobetter Sales YoY (2018-2029) & (K Units)
Figure 30. Asia (excluding China) Biobetter Revenue YoY (2018-2029) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Biobetter Sales YoY (2018-2029) & (K Units)
Figure 32. Middle East, Africa and Latin America Biobetter Revenue YoY (2018-2029) & (US$ Million)
Figure 33. The Biobetter Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 34. The Top 5 and 10 Largest Manufacturers of Biobetter in the World: Market Share by Biobetter Revenue in 2022
Figure 35. Global Biobetter Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Global Biobetter Sales Market Share by Type (2018-2029)
Figure 37. Global Biobetter Revenue Market Share by Type (2018-2029)
Figure 38. Global Biobetter Sales Market Share by Application (2018-2029)
Figure 39. Global Biobetter Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Biobetter Sales Market Share by Type (2018-2029)
Figure 41. US & Canada Biobetter Revenue Market Share by Type (2018-2029)
Figure 42. US & Canada Biobetter Sales Market Share by Application (2018-2029)
Figure 43. US & Canada Biobetter Revenue Market Share by Application (2018-2029)
Figure 44. US & Canada Biobetter Revenue Share by Country (2018-2029)
Figure 45. US & Canada Biobetter Sales Share by Country (2018-2029)
Figure 46. U.S. Biobetter Revenue (2018-2029) & (US$ Million)
Figure 47. Canada Biobetter Revenue (2018-2029) & (US$ Million)
Figure 48. Europe Biobetter Sales Market Share by Type (2018-2029)
Figure 49. Europe Biobetter Revenue Market Share by Type (2018-2029)
Figure 50. Europe Biobetter Sales Market Share by Application (2018-2029)
Figure 51. Europe Biobetter Revenue Market Share by Application (2018-2029)
Figure 52. Europe Biobetter Revenue Share by Country (2018-2029)
Figure 53. Europe Biobetter Sales Share by Country (2018-2029)
Figure 54. Germany Biobetter Revenue (2018-2029) & (US$ Million)
Figure 55. France Biobetter Revenue (2018-2029) & (US$ Million)
Figure 56. U.K. Biobetter Revenue (2018-2029) & (US$ Million)
Figure 57. Italy Biobetter Revenue (2018-2029) & (US$ Million)
Figure 58. Russia Biobetter Revenue (2018-2029) & (US$ Million)
Figure 59. China Biobetter Sales Market Share by Type (2018-2029)
Figure 60. China Biobetter Revenue Market Share by Type (2018-2029)
Figure 61. China Biobetter Sales Market Share by Application (2018-2029)
Figure 62. China Biobetter Revenue Market Share by Application (2018-2029)
Figure 63. Asia Biobetter Sales Market Share by Type (2018-2029)
Figure 64. Asia Biobetter Revenue Market Share by Type (2018-2029)
Figure 65. Asia Biobetter Sales Market Share by Application (2018-2029)
Figure 66. Asia Biobetter Revenue Market Share by Application (2018-2029)
Figure 67. Asia Biobetter Revenue Share by Region (2018-2029)
Figure 68. Asia Biobetter Sales Share by Region (2018-2029)
Figure 69. Japan Biobetter Revenue (2018-2029) & (US$ Million)
Figure 70. South Korea Biobetter Revenue (2018-2029) & (US$ Million)
Figure 71. China Taiwan Biobetter Revenue (2018-2029) & (US$ Million)
Figure 72. Southeast Asia Biobetter Revenue (2018-2029) & (US$ Million)
Figure 73. India Biobetter Revenue (2018-2029) & (US$ Million)
Figure 74. Middle East, Africa and Latin America Biobetter Sales Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Biobetter Revenue Market Share by Type (2018-2029)
Figure 76. Middle East, Africa and Latin America Biobetter Sales Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Biobetter Revenue Market Share by Application (2018-2029)
Figure 78. Middle East, Africa and Latin America Biobetter Revenue Share by Country (2018-2029)
Figure 79. Middle East, Africa and Latin America Biobetter Sales Share by Country (2018-2029)
Figure 80. Brazil Biobetter Revenue (2018-2029) & (US$ Million)
Figure 81. Mexico Biobetter Revenue (2018-2029) & (US$ Million)
Figure 82. Turkey Biobetter Revenue (2018-2029) & (US$ Million)
Figure 83. Israel Biobetter Revenue (2018-2029) & (US$ Million)
Figure 84. GCC Countries Biobetter Revenue (2018-2029) & (US$ Million)
Figure 85. Biobetter Value Chain
Figure 86. Biobetter Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed